Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChina-Japan Friendship Hospital

About this trial

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), combined with endobronchial biopsy (EBB) and/or transbronchial lung biopsy (TBLB), and endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) have high diagnostic yields for patients with sarcoidosis. However, a direct comparison between them has not been conducted. This randomized controlled trial aims to compare directly the diagnostic yield between EBUS-TBMC and EBUS-TBNA+EBB+TBLB in sarcoidosis.

Eligibility criteria

Qualifiers

Age ≥18years;

Patients with clinical and radiological suspicion of stage I or stage II sarcoidosis;

Fully informed of the purpose and method of the study

Disqualifiers

Pathologically confirmed sarcoidosis, obvious organ involvement with the possibility of confirming granulomas using a minimally invasive diagnostic procedure;

Patients with medical contraindications to bronchoscopy procedures.

Trial design

Treatments tested in this trial

  • EBUS-TBNA-based sampling methods
  • EBUS-TBMC based sampling method

Treatment groups

469 Participants
are divided into 2 treatment groups

Locations

This trial has no locations